Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082–97.

Article  PubMed  Google Scholar 

Collaborators USBoD, Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, et al. The State of US Health, 1990–2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319(14):1444–72.

Article  Google Scholar 

Pain S. Painful progress. Nature. 2016;535(7611):S18–9.

Article  PubMed  Google Scholar 

Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kreek MJ, Reed B, Butelman ER. Current status of opioid addiction treatment and related preclinical research. Sci Adv. 2019;5(10):eaax9140.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241–8.

Article  PubMed  Google Scholar 

Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, Johns N, et al. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction. 2014;109(8):1320–33.

Article  PubMed  Google Scholar 

Ding H, Kiguchi N, Mabry KM, Kishioka S, Ko MC. Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates. Neuropharmacology. 2023;223: 109328.

Article  CAS  PubMed  Google Scholar 

Corbett AD, Henderson G, McKnight AT, Paterson SJ. 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol. 2006;147(Suppl 1):S153–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Günther T, Dasgupta P, Mann A, Miess E, Kliewer A, Fritzwanker S, et al. Targeting multiple opioid receptors—improved analgesics with reduced side effects? Br J Pharmacol. 2018;175(14):2857–68.

Article  PubMed  Google Scholar 

Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N Engl J Med. 2017;377(4):391–4.

Article  PubMed  Google Scholar 

Woolf CJ. Capturing novel non-opioid pain targets. Biol Psychiatry. 2020;87(1):74–81.

Article  PubMed  Google Scholar 

Attal N, Bouhassira D. Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? Pain. 2015;156(Suppl 1):S104–14.

Article  PubMed  Google Scholar 

Nilius B, Szallasi A. Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine. Pharmacol Rev. 2014;66(3):676–814.

Article  PubMed  Google Scholar 

Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol Rev. 2014;94(1):265–301.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yekkirala AS, Roberson DP, Bean BP, Woolf CJ. Breaking barriers to novel analgesic drug development. Nat Rev Drug Discov. 2017;16(8):545–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wise BL, Seidel MF, Lane NE. The evolution of nerve growth factor inhibition in clinical medicine. Nat Rev Rheumatol. 2021;17(1):34–46.

Article  PubMed  Google Scholar 

Kiguchi N, Ko MC. Potential therapeutic targets for the treatment of opioid abuse and pain. Adv Pharmacol. 2022;93:335–71.

Article  CAS  PubMed  Google Scholar 

Ding H, Ko MC. Translational value of non-human primates in opioid research. Exp Neurol. 2021;338: 113602.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calo’ G, Guerrini R. Medicinal chemistry, pharmacology, and biological actions of peptide ligands selective for the nociceptin/orphanin FQ receptor. In: Ko MC, Husbands SM, editors. Research and development of opioid-related ligands. Washington, DC: American Chemical Society; 2013. p. 275–325.

Chapter  Google Scholar 

Lin AP, Ko MC. The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability. ACS Chem Neurosci. 2013;4(2):214–24.

Article  CAS  PubMed  Google Scholar 

Toll L, Bruchas MR, Calo G, Cox BM, Zaveri NT. Nociceptin/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev. 2016;68(2):419–57.

Article  PubMed  PubMed Central  Google Scholar 

Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 1994;347(2–3):284–8.

Article  CAS  PubMed  Google Scholar 

Fukuda K, Kato S, Mori K, Nishi M, Takeshima H, Iwabe N, et al. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 1994;343(1):42–6.

Article  CAS  PubMed  Google Scholar 

Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 1994;341(1):33–8.

Article  CAS  PubMed  Google Scholar 

Nishi M, Takeshima H, Mori M, Nakagawara K, Takeuchi T. Structure and chromosomal mapping of genes for the mouse kappa-opioid receptor and an opioid receptor homologue (MOR-C). Biochem Biophys Res Commun. 1994;205(2):1353–7.

Article  CAS  PubMed  Google Scholar 

Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM, et al. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 1994;348(1):759.

Article  Google Scholar 

Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science. 1992;258(5090):1952–5.

Article  CAS  PubMed  Google Scholar 

Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA. 1992;89(24):12048–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Mestek A, Liu J, Hurley JA, Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol. 1993;44(1):8–12.

CAS  PubMed  Google Scholar 

Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, et al. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci USA. 1993;90(14):6736–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 1995;377(6549):532–5.

Article  CAS  PubMed  Google Scholar 

Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 1995;270(5237):792–4.

Article  CAS  PubMed  Google Scholar 

Cox BM, Christie MJ, Devi L, Toll L, Traynor JR. Challenges for opioid receptor nomenclature: IUPHAR review 9. Br J Pharmacol. 2015;172(2):317–23.

Article  CAS  PubMed  Google Scholar 

Sundstrom G, Dreborg S, Larhammar D. Concomitant duplications of opioid peptide and receptor genes before the origin of jawed vertebrates. PLoS ONE. 2010;5(5): e10512.

Article  PubMed  PubMed Central  Google Scholar 

Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, et al. Structure of the delta-opioid receptor bound to naltrindole. Nature. 2012;485(7398):400–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, et al. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature. 2012;485(7398):321–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thompson AA, Liu W, Chun E, Katritch V, Wu H, Vardy E, et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature. 2012;485(7398):395–9.